Enfortumab Vedotin in Advanced Urothelial Carcinoma. Reply
- PMID: 34192441
- DOI: 10.1056/NEJMc2106975
Enfortumab Vedotin in Advanced Urothelial Carcinoma. Reply
Comment on
-
Enfortumab Vedotin in Advanced Urothelial Carcinoma.N Engl J Med. 2021 Jul 1;385(1):93. doi: 10.1056/NEJMc2106975. N Engl J Med. 2021. PMID: 34192440 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical